Professor Owen Smith, Consultant Paediatric Haematologist at Children’s Health Ireland (CHI), has launched Ireland’s first clinical study of genomics approaches in cancer care.
Genomic sequencing allows medical teams to better identify cancerous cells and target them specifically.
“We need to stop carpet bombing cancers and go for a more sniper fire or precision way of killing the cancer and reducing the side effects to the patient,” Prof Smith said.
“Genomic sequencing of the cancer and the patient will allow us to define the patients where chemotherapy can be safely reduced,”
The primary objective of MAGIC-I is to evaluate the clinical and health economic impact of implementing genomic diagnostics in paediatric cancer care in Ireland.
Lynch Syndrome Ireland 